Literature DB >> 23389960

Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells.

Minyi He1, Yun Liu, Xinjun Deng, Songtao Qi, Xuegang Sun, Gang Liu, Yongguang Liu, Yawei Liu, Ming Zhao.   

Abstract

BACKGROUND: An increasing body of evidence indicates that microRNAs play critical roles in androgen-independent prostate cancer (AIPC) growth. However, the regulation of the expression of microRNAs in AIPC is not very clear. In this study, we investigated the role that the interaction between miR-200b-3p and p73 plays in the proliferation of AIPC.
METHODS: We compared several relevant microRNAs and cancer related genes between the androgen-dependent prostate cancer (ADPC) cell line and the AIPC cell line using quantitative real-time PCR (Q-PCR) and Western blot. Then we examined the effect of p73 and miR-200b-3p on the proliferation of AIPC and ADPC using CCK-8. Furthermore we investigated the regulation of miR-200b-3p by p73.
RESULTS: p73 and miR-200b-3p were both downregulated in the PC3 cell line (AIPC). Down-regulation of both p73 and miR-200b-3p increased the proliferation of ADPC cells cultured with androgen-free medium, while up-regulation of p73 and miR-200b-3p decreased the proliferation of AIPC cells. When p73 was over-expressed in the AIPC cell subline, miR-200b-3p expression increased accordingly, while p73 was inhibited in ADPC cells cultured with androgen-free medium and miR-200b-3p expression decreased significantly.
CONCLUSION: miR-200b-3p is down-regulated by low expression of p73 in AIPC cells, and this interaction contributes to the proliferation of AIPC.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389960     DOI: 10.1002/pros.22652

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  20 in total

1.  Upregulated has-miR-4516 as a potential biomarker for early diagnosis of dust-induced pulmonary fibrosis in patients with pneumoconiosis.

Authors:  Ruixue Huang; Ting Yu; Ying Li; Jianan Hu
Journal:  Toxicol Res (Camb)       Date:  2018-02-08       Impact factor: 3.524

Review 2.  MicroRNAs and drug resistance in prostate cancers.

Authors:  Feng Li; Ram I Mahato
Journal:  Mol Pharm       Date:  2014-04-29       Impact factor: 4.939

3.  miR-200b as a prognostic factor targets multiple members of RAB family in glioma.

Authors:  Qing Liu; Hailin Tang; Xiaoping Liu; Yiwei Liao; Haoyu Li; Zijin Zhao; Xianrui Yuan; Weixi Jiang
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

4.  Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer.

Authors:  Feng Li; Tingting Lu; Dongmei Liu; Chong Zhang; Yonghui Zhang; Fulu Dong
Journal:  Cell Death Dis       Date:  2021-05-22       Impact factor: 8.469

5.  miR‑200b upregulation promotes migration of BEAS‑2B cells following long‑term exposure to cigarette smoke by targeting ETS1.

Authors:  Jin Wang; Ruixin Yao; Qiulin Luo; Lirong Tan; Beibei Jia; Nan Ouyang; Yezhou Li; Jian Tong; Jianxiang Li
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

6.  Stability Assessment of Candidate Reference Genes in Urine Sediment of Prostate Cancer Patients for miRNA Applications.

Authors:  Maria Giulia Egidi; Giovanni Cochetti; Gabriella Guelfi; Danilo Zampini; Silvana Diverio; Giulia Poli; Ettore Mearini
Journal:  Dis Markers       Date:  2015-05-20       Impact factor: 3.434

Review 7.  Systematic enrichment analysis of microRNA expression profiling studies in endometriosis.

Authors:  Shiyang Wei; Hong Xu; Yan Kuang
Journal:  Iran J Basic Med Sci       Date:  2015-05       Impact factor: 2.699

8.  miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.

Authors:  Feng Ye; Hailin Tang; Qing Liu; Xinhua Xie; Minqing Wu; Xiaoping Liu; Bo Chen; Xiaoming Xie
Journal:  J Transl Med       Date:  2014-01-21       Impact factor: 5.531

9.  miR-200b inhibits prostate cancer EMT, growth and metastasis.

Authors:  LaTanya V Williams; Dorina Veliceasa; Elena Vinokour; Olga V Volpert
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Expression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide.

Authors:  Hai Wang; Wenfeng Feng; Yuntao Lu; Hezhen Li; Wei Xiang; Ziyang Chen; Minyi He; Liang Zhao; Xuegang Sun; Bingxi Lei; Songtao Qi; Yawei Liu
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.